Form 4: LeMaitre Vascular CEO George LeMaitre Sells Shares Under 10b5-1 Plan

George LeMaitre, Chairman and CEO of LeMaitre Vascular, sold a total of 40,006 shares of common stock on July 12 and July 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, sold shares of the company's common stock.
• On July 12, 2024, he sold 12,976 shares at a weighted average price of $86.07.
• On July 15, 2024, he sold 27,030 shares at a weighted average price of $86.2711.
• These transactions were executed under a 10b5-1(c) trading plan adopted on June 2, 2023.
• Following these sales, Mr. LeMaitre directly owns 1,958,328 shares of LeMaitre Vascular.

Sentiment

Score: 5

Explanation: The document simply reports insider selling under a pre-arranged plan, which is neither particularly positive nor negative. It's a neutral event.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current market information.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates